Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, December 2014

Sort by: Newest first Oldest first A-Z Z-A

  • Xagrid in the paediatric population Subscription

    11 DEC 2014 13:21

    The summary of product characteristics of Xagrid (anagrelide hydrochloride; Shire) has been updated to include more information on how to use the medicine to treat children, following the completion of a paediatric investigation plan. 

  • Use of antiretroviral therapy could contribute to a reduction in HIV virulence at the population level, study finds

    Use of antiretroviral therapy will drive down HIV virulence Subscription

    15 DEC 2014 16:35
    Comments (1)

    HIV is evolving relatively rapidly, which is contributing to a reduction in HIV virulence at the population level, say researchers writing in PNAS.

  • Uruguay delays plans to allow the sale of cannabis for recreational purposes in pharmacies

    Uruguay delays plans to sell cannabis in pharmacies Subscription

    4 DEC 2014 11:13 By Bernard Murphy

    Marijuana will not be sold in pharmacies in Uruguay until March 2015, the National Drugs Board (JND) has announced.

  • Reema Caddies, telepharmacist for helpline NHS 111 at Yorkshire Ambulance Service and Local Care Direct

    Triaging urgent care patients via a non-emergency telephone helpline Subscription

    1 DEC 2014 0:00 By Reema Caddies

    Reema Caddies splits her time working between urgent care helpline NHS 111 at Yorkshire Ambulance Service and managing medicines for Local Care Direct, which operates an out-of-hours GP service.

  • Survey suggests US doctors are changing their prescribing habits for opioid drugs Subscription

    9 DEC 2014 12:14

    Many primary care physicians are less likely to prescribe opioids now than a year ago, according to a survey of US doctors.

  • Strength of Duphalac Subscription

    5 DEC 2014 14:23

    The strength of Duphalac (lactulose; Abbott) solution had been amended from 3.35g/5ml to 3.335g/5ml on the summary of product characteristics. The actual strength of the product has not changed, only the way that it is expressed.

  • Stelara side effects Subscription

    11 DEC 2014 11:04

    Skin exfoliation and exfoliative dermatitis have been added to the list of uncommon and rare side effects associated with Stelara (ustekinumab; Janssen-Cilag), respectively, in the medicine’s summary of product characteristics. If these symptoms occur, appropriate therapy should be instituted and ustekinumab discontinued. 

  • SMC December 2014 decisions Subscription

    18 DEC 2014 10:31

    In the latest round of decisions by the Scottish Medicines Consortium(SMC), a number of medicines have been accepted for use in NHS Scotland; obinutuzumab (Gazyvaro; Roche), pemetrexed (Alimta; Eli Lilly), pomalidomide (Imnovid; Celegene), umeclidinium (Incruse; GlaxoSmithKline), cholecalciferol 25,000 international units oral solution ...

  • Robert Blyth, former PJ editor, dies Subscription

    3 DEC 2014 15:59

    Robert Blyth, FRPharmS, who edited The Pharmaceutical Journal from 1961 to 1986, has died. A pharmaceutical journalist for the greater part of his career, he died on 27 November 2014, aged 93.

  • Risk of hyperglycaemia for diabetes patients using faulty insulin pens Subscription

    17 DEC 2014 16:45

    People with diabetes using insulin pens from a number of faulty batches manufactured by Owen Mumford are at risk of hyperglycaemia.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.